// App-Quantinova.ai

2321 : Ibrutinib enhances antitumor activity in solid tumors when combined with checkpoint inhibitors

Researchers

Presenter

  • Jeff Hsu

Principal Investigators

  • Yujun Huang

  • Chun-Te Chen

  • Jun Chen

  • Mint Sirisawad

  • Betty Y. Chang

Medical Centers

  • Pharmcyclics LLC, an AbbVie Company, Sunnyvale, CA

Locations

  • United States

Companies

  • Pharmacyclics LLC

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Ibrutinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved